StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$56.95+1.58 (+2.85%)

Close on Nov 18, 2026Market cap $3.40BP/E –Yield –

Axogen operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Axogen's operating income for the twelve months ending Sep 30, 2026 was -$13.81M, down 450.4% year over year. For fiscal 2025 it was -$7.85M. The highest annual figure on record is -$3.29M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.85M–
FY2024Dec 31, 2024-$3.29M–
FY2023Dec 31, 2023-$21.46M–
FY2022Dec 31, 2022-$29.71M–
FY2021Dec 31, 2021-$25.42M–
FY2020Dec 31, 2020-$23.18M–
FY2019Dec 31, 2019-$31.41M–
FY2018Dec 31, 2018-$20.50M–
FY2017Dec 31, 2017-$7.95M–
FY2016Dec 31, 2016-$8.13M–
FY2015Dec 31, 2015-$9.27M–
FY2014Dec 31, 2014-$9.80M–
FY2013Dec 31, 2013-$9.59M–
FY2012Dec 31, 2012-$7.80M–
FY2011Dec 31, 2011-$6.97M–
FY2010Dec 31, 2010-$4.48M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$955.00K-50.1%
Q2 FY2026Jun 30, 2026-$2.16M-228.9%
Q1 FY2026Mar 31, 2026-$2.83M–
Q4 FY2025Dec 31, 2025-$9.77M-584.5%
Q3 FY2025Sep 30, 2025$1.91M–
Q2 FY2025Jun 30, 2025$1.67M–
Q1 FY2025Mar 31, 2025-$1.66M–
Q4 FY2024Dec 31, 2024$2.02M–
Q3 FY2024Sep 30, 2024-$316.00K–
Q2 FY2024Jun 30, 2024-$428.00K–
Q1 FY2024Mar 31, 2024-$4.56M–
Q4 FY2023Dec 31, 2023-$3.19M–
Q3 FY2023Sep 30, 2023-$4.03M–
Q2 FY2023Jun 30, 2023-$6.90M–
Q1 FY2023Mar 31, 2023-$7.34M–
Q4 FY2022Dec 31, 2022-$5.61M–
Q3 FY2022Sep 30, 2022-$4.86M–
Q2 FY2022Jun 30, 2022-$7.92M–
Q1 FY2022Mar 31, 2022-$11.32M–
Q4 FY2021Dec 31, 2021-$5.35M–
Q3 FY2021Sep 30, 2021-$6.69M–
Q2 FY2021Jun 30, 2021-$7.15M–
Q1 FY2021Mar 31, 2021-$6.22M–
Q4 FY2020Dec 31, 2020-$5.37M–
Q3 FY2020Sep 30, 2020-$1.05M–
Q2 FY2020Jun 30, 2020-$8.25M–
Q1 FY2020Mar 31, 2020-$8.51M–
Q4 FY2019Dec 31, 2019-$7.42M–
Q3 FY2019Sep 30, 2019-$6.11M–
Q2 FY2019Jun 30, 2019-$7.67M–
Q1 FY2019Mar 31, 2019-$10.20M–
Q4 FY2018Dec 31, 2018-$5.86M–
Q3 FY2018Sep 30, 2018-$4.84M–
Q2 FY2018Jun 30, 2018-$4.82M–
Q1 FY2018Mar 31, 2018-$4.99M–
Q4 FY2017Dec 31, 2017-$1.81M–
Q3 FY2017Sep 30, 2017-$1.50M–
Q2 FY2017Jun 30, 2017-$1.45M–
Q1 FY2017Mar 31, 2017-$3.20M–
Q4 FY2016Dec 31, 2016-$2.72M–

More Axogen figures

See a number that looks wrong?